Alberta Investment Management Corp Bridge Bio Pharma, Inc. Transaction History

Alberta Investment Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $112,884 - $152,344	4,908 Added 20.26%	29,133 $737,000
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $662,553 - $979,901	24,225 New	24,225 $749,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $7.34 Million - $17.2 Million	-1,000,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.38 - $53.41 $7.97 Million - $37.4 Million	700,000 Added 233.33%	1,000,000 $16.7 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $14.1 Million - $19.3 Million	300,000 New	300,000 $14.1 Million

295

170M

10.4M

2.36M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.5B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.